Qube Research & Technologies LTD Neuro Sense Therapeutics Ltd. Transaction History
Qube Research & Technologies LTD
- $61.9 Billion
- Q1 2024
A detailed history of Qube Research & Technologies LTD transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 54 shares of NRSN stock, worth $45. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54
Previous 54
-0.0%
Holding current value
$45
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NRSN
# of Institutions
9Shares Held
167KCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny71.1KShares$60,4350.0% of portfolio
-
Meitav Dash Investments LTD50KShares$42,5000.0% of portfolio
-
Woodline Partners LP San Francisco, CA19.6KShares$16,6430.0% of portfolio
-
Geode Capital Management, LLC Boston, MA12KShares$10,1680.0% of portfolio
-
Ubs Group Ag11.9KShares$10,1380.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $9.92M